These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29205621)

  • 1. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.
    Kim J; Moestue SA; Bathen TF; Kim E
    Tomography; 2019 Sep; 5(3):308-319. PubMed ID: 31572792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer Xenografts.
    Kazmierczak PM; Schneider M; Habereder T; Hirner-Eppeneder H; Eschbach RS; Moser M; Reiser MF; Lauber K; Nikolaou K; Cyran CC
    Invest Radiol; 2016 Nov; 51(11):746-755. PubMed ID: 27082316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.
    Moestue SA; Huuse EM; Lindholm EM; Bofin A; Engebraaten O; Mælandsmo GM; Akslen LA; Gribbestad IS
    J Magn Reson Imaging; 2013 Nov; 38(5):1043-53. PubMed ID: 23908122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
    Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
    J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of bevacizumab-induced antiangiogenic treatment effects by "steady state" ultrasmall superparamagnetic iron oxide particles magnetic resonance imaging using robust multiecho ΔR2* relaxometry.
    Ring J; Persigehl T; Remmele S; Heindel W; Dahnke H; Bremer C
    Invest Radiol; 2011 May; 46(5):326-30. PubMed ID: 21358548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
    Beaumont M; Lemasson B; Farion R; Segebarth C; Rémy C; Barbier EL
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1714-26. PubMed ID: 19584891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.
    Yang SH; Lin J; Lu F; Dai YY; Han ZH; Fu CX; Hu FL; Gu HC
    J Magn Reson Imaging; 2016 Aug; 44(2):288-95. PubMed ID: 26808392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses.
    Shi Q; Pisani LJ; Lee YK; Messing S; Ansari C; Bhaumik S; Lowery L; Lee BD; Meyer DE; Daldrup-Link HE
    Contrast Media Mol Imaging; 2013; 8(3):281-8. PubMed ID: 23606432
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wang Y; Liu H; Yao D; Li J; Yang S; Zhang C; Chen W; Wang D
    J Nanobiotechnology; 2019 Oct; 17(1):105. PubMed ID: 31604441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
    de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
    Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory imaging with ultrasmall superparamagnetic iron oxide.
    Matsushita T; Kusakabe Y; Fujii H; Murase K; Yamazaki Y; Murase K
    Magn Reson Imaging; 2011 Feb; 29(2):173-8. PubMed ID: 20850245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro distinction between proinflammatory and antiinflammatory macrophages with gadolinium-liposomes and ultrasmall superparamagnetic iron oxide particles at 3.0T.
    Khaled W; Piraquive J; Leporq B; Wan JH; Lambert SA; Mignet N; Doan BT; Lotersztajn S; Garteiser P; Van Beers BE
    J Magn Reson Imaging; 2019 Apr; 49(4):1166-1173. PubMed ID: 30390366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic multi-echo DCE- and DSC-MRI in rectal cancer: Low primary tumor K
    Grøvik E; Redalen KR; Storås TH; Negård A; Holmedal SH; Ree AH; Meltzer S; Bjørnerud A; Gjesdal KI
    J Magn Reson Imaging; 2017 Jul; 46(1):194-206. PubMed ID: 28001320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
    Boult JK; Borri M; Jury A; Popov S; Box G; Perryman L; Eccles SA; Jones C; Robinson SP
    NMR Biomed; 2016 Nov; 29(11):1608-1617. PubMed ID: 27671990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.
    Kim E; Kim J; Maelandsmo GM; Johansen B; Moestue SA
    Magn Reson Med; 2017 Oct; 78(4):1513-1522. PubMed ID: 27888545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
    Gambarota G; Leenders W; Maass C; Wesseling P; van der Kogel B; van Tellingen O; Heerschap A
    Br J Cancer; 2008 Jun; 98(11):1784-9. PubMed ID: 18506183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.